Great Lakes Advisors LLC Invests $2.70 Million in Addus HomeCare Corporation $ADUS

Great Lakes Advisors LLC bought a new stake in Addus HomeCare Corporation (NASDAQ:ADUS) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 26,836 shares of the company’s stock, valued at approximately $2,696,000. Great Lakes Advisors LLC owned about 0.14% of Addus HomeCare at the end of the most recent quarter.

Other large investors also recently made changes to their positions in the company. Global Retirement Partners LLC grew its holdings in Addus HomeCare by 395.7% in the 4th quarter. Global Retirement Partners LLC now owns 233 shares of the company’s stock valued at $25,000 after buying an additional 186 shares in the last quarter. Larson Financial Group LLC increased its position in Addus HomeCare by 133.3% during the 3rd quarter. Larson Financial Group LLC now owns 238 shares of the company’s stock worth $28,000 after buying an additional 136 shares during the period. Acumen Wealth Advisors LLC acquired a new stake in shares of Addus HomeCare during the fourth quarter worth $29,000. Private Trust Co. NA lifted its holdings in shares of Addus HomeCare by 65.5% during the fourth quarter. Private Trust Co. NA now owns 283 shares of the company’s stock worth $30,000 after buying an additional 112 shares in the last quarter. Finally, Arax Advisory Partners boosted its position in shares of Addus HomeCare by 95.8% in the fourth quarter. Arax Advisory Partners now owns 280 shares of the company’s stock valued at $30,000 after acquiring an additional 137 shares during the period. Institutional investors own 95.35% of the company’s stock.

Addus HomeCare Stock Up 0.4%

ADUS stock opened at $120.55 on Friday. Addus HomeCare Corporation has a 52 week low of $87.95 and a 52 week high of $124.43. The business has a 50-day simple moving average of $108.92 and a 200 day simple moving average of $102.37. The company has a quick ratio of 1.69, a current ratio of 1.69 and a debt-to-equity ratio of 0.05. The company has a market cap of $2.25 billion, a PE ratio of 21.15, a price-to-earnings-growth ratio of 1.61 and a beta of 0.87.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings data on Monday, August 3rd. The company reported $1.73 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.70 by $0.03. Addus HomeCare had a net margin of 7.13% and a return on equity of 9.96%. The firm had revenue of $377.41 million for the quarter, compared to the consensus estimate of $376.24 million. During the same period in the prior year, the company posted $1.49 earnings per share. The business’s revenue for the quarter was up 8.0% on a year-over-year basis. Sell-side analysts anticipate that Addus HomeCare Corporation will post 6.29 EPS for the current fiscal year.

Insider Buying and Selling at Addus HomeCare

In other news, insider Heather Brianne Dixon sold 288 shares of the company’s stock in a transaction that occurred on Monday, June 22nd. The shares were sold at an average price of $93.77, for a total transaction of $27,005.76. Following the completion of the sale, the insider owned 44,371 shares of the company’s stock, valued at approximately $4,160,668.67. This represents a 0.64% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 4.10% of the company’s stock.

Analyst Upgrades and Downgrades

ADUS has been the topic of several research reports. Royal Bank Of Canada upped their price target on shares of Addus HomeCare from $130.00 to $134.00 and gave the company an “outperform” rating in a research note on Wednesday, August 5th. Weiss Ratings upgraded shares of Addus HomeCare from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, July 9th. Citigroup restated a “market outperform” rating on shares of Addus HomeCare in a research report on Friday, July 24th. Barclays boosted their price target on Addus HomeCare from $92.00 to $96.00 and gave the company an “underweight” rating in a research note on Wednesday, July 8th. Finally, Citizens Jmp reissued a “market outperform” rating and set a $142.00 price target on shares of Addus HomeCare in a research report on Monday, May 18th. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $130.88.

Addus HomeCare Profile

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.